亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Phase I Clinical Trial of Islet Antigen–Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes

1型糖尿病 医学 临床试验 小岛 免疫学 质粒 糖尿病 免疫系统 疾病 dna疫苗 免疫耐受 干扰素 抗原 2型糖尿病 病毒学 临床研究阶段 Ⅰ型干扰素 自身免疫性疾病 胰岛素 内科学 重组DNA
作者
Carla J. Greenbaum,S. Alice Long,Stephen Eric Gitelman,JASON L. GAGLIA,Mark Daniels,Todd M. Brusko,Sandra M. Lord,Brian N. Bundy,Jeffrey P. Krischer,Michael J. Haller,Andrea K. Steck,Linda Anne DiMeglio,Carmella Evans‐Molina,Antoinette Moran,Priya Prahalad,Darrell M. Wilson,William E. Russell,Jennifer L. Sherr,Philip Raskin,Mark Allen Clements
出处
期刊:Diabetes [American Diabetes Association]
卷期号:75 (3): 506-518 被引量:3
标识
DOI:10.2337/db25-0777
摘要

There is significant interest in antigen-specific approaches to delaying type 1 diabetes in preclinical stages and supporting tolerance after diagnosis. We conducted a phase I trial of a nonintegrating DNA plasmid constructed to secrete the type 1 diabetes antigen preproinsulin (PPI) and the immune modulatory cytokines transforming growth factor-β1 (TGF-β1), interleukin-10 (IL-10), and IL-2. In this placebo-controlled, double-masked study of 47 adults with stage 3 type 1 diabetes, we showed that the drug is safe and well tolerated, with most reported adverse events (AEs) categorized as grade 1 and with no clinically significant difference in AEs among treatment groups. There were no untoward metabolic or immune effects. We found pharmacodynamic evidence of treatment, as demonstrated by a dose-dependent type 1 interferon (IFN) signature. Plasmid DNA, representing a pharmocokinetic measure, was detected in the two highest dosing groups. We did not find global or antigen-specific immune cell changes following treatment with a DNA plasmid expressing PPI, IL-2, IL-10, and TGF-β1, and we did not detect immune changes driven by IL-2, IL-10, or TGF-β1. Our results support further trials of this novel tolerizing antigen construct. ARTICLE HIGHLIGHTS: Antigen-specific therapy is needed to induce tolerance in type 1 diabetes at early disease stages or in combination with immunotherapy. We conducted a phase I trial in type 1 diabetes of a novel plasmid construct expressing the islet antigen preproinsulin (PPI) and immunomodulatory cytokines transforming growth factor-β1 (TGF-β1), interleukin-10 (IL-10), and IL-2. The therapy was safe and well tolerated. Dose-dependent changes in DNA plasmid levels and type 1 interferon signatures were detected; however, global and antigen-specific immune changes to PPI, IL-2, IL-10, or TGF-β1 were not observed. Further trials are needed to assess efficacy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
上官若男的应助被爱学习的doge采纳,获得10
6秒前
星辰大海的应助被爱学习的doge采纳,获得10
6秒前
爆米花的应助被爱学习的doge采纳,获得10
6秒前
FashionBoy的应助被爱学习的doge采纳,获得10
6秒前
bkagyin的应助被爱学习的doge采纳,获得10
6秒前
传奇3的应助被爱学习的doge采纳,获得30
6秒前
小马甲的应助被爱学习的doge采纳,获得10
6秒前
斯文败类的应助被爱学习的doge采纳,获得10
7秒前
汉堡包的应助被爱学习的doge采纳,获得10
7秒前
7秒前
10秒前
乐乐的应助被爱学习的doge采纳,获得10
13秒前
丘比特的应助被爱学习的doge采纳,获得10
13秒前
bkagyin的应助被爱学习的doge采纳,获得10
13秒前
Orange的应助被爱学习的doge采纳,获得10
13秒前
领导范儿的应助被爱学习的doge采纳,获得30
13秒前
我是老大的应助被爱学习的doge采纳,获得10
13秒前
情怀的应助被爱学习的doge采纳,获得10
13秒前
打打的应助被爱学习的doge采纳,获得10
13秒前
香蕉觅云的应助被爱学习的doge采纳,获得10
13秒前
传奇3的应助被爱学习的doge采纳,获得10
13秒前
14秒前
16秒前
17秒前
无语的新之完成签到,获得积分10
17秒前
17秒前
17秒前
18秒前
18秒前
18秒前
科研通AI6.2的应助被Mario采纳,获得10
18秒前
18秒前
Orange的应助被Mario采纳,获得10
18秒前
18秒前
18秒前
19秒前
19秒前
19秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179936
求助须知:如何正确求助?哪些是违规求助? 9570159
关于积分的说明 21808414
捐赠科研通 7775767
什么是DOI,文献DOI怎么找? 3433224
关于科研通互助平台的介绍 2557347
邀请新用户注册赠送积分活动 2478929